What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Cardiology
His main research concerns Internal medicine, Pathology, Thrombosis, Thrombus and Cardiology.
His studies in Internal medicine integrate themes in fields like Endocrinology and Type 2 Diabetes Mellitus.
His work deals with themes such as Magnetic resonance imaging, Matrix metalloproteinase and Vascular disease, which intersect with Pathology.
The study incorporates disciplines such as Hemostasis, Platelet, Fibrin and Tissue factor in addition to Thrombosis.
His Thrombus research includes themes of Artery, Inhalation, Antithrombotic, Heparin and Disease.
His biological study spans a wide range of topics, including Restenosis and Surgery.
His most cited work include:
- The pathogenesis of coronary artery disease and the acute coronary syndromes (1). (3515 citations)
- From Vulnerable Plaque to Vulnerable Patient A Call for New Definitions and Risk Assessment Strategies: Part I (2483 citations)
- From Vulnerable Plaque to Vulnerable Patient (883 citations)
What are the main themes of his work throughout his whole career to date?
Juan J. Badimon mainly focuses on Internal medicine, Cardiology, Thrombosis, Thrombus and Platelet.
His study brings together the fields of Endocrinology and Internal medicine.
His work on Angioplasty, Unstable angina and Clopidogrel as part of his general Cardiology study is frequently connected to In patient, thereby bridging the divide between different branches of science.
Juan J. Badimon interconnects Artery and Pathology in the investigation of issues within Thrombosis.
His Pathology study which covers Vascular disease that intersects with Magnetic resonance imaging.
His Platelet research incorporates elements of Ex vivo, Pharmacology and Perfusion.
He most often published in these fields:
- Internal medicine (54.36%)
- Cardiology (37.85%)
- Thrombosis (19.11%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (54.36%)
- Cardiology (37.85%)
- Heart failure (5.38%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Cardiology, Heart failure, Empagliflozin and Pharmacology.
His Internal medicine study frequently links to other fields, such as Diabetes mellitus.
His Heart failure research incorporates themes from Ketone bodies and Canagliflozin.
Juan J. Badimon combines subjects such as Agonist, Receptor, Platelet, Thrombin and Reperfusion injury with his study of Pharmacology.
His work carried out in the field of Platelet brings together such families of science as Ex vivo and Intensive care medicine.
The Antithrombotic study combines topics in areas such as Thrombosis, Thrombogenicity, Thrombus and Placebo.
Between 2014 and 2021, his most popular works were:
- Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics. (130 citations)
- Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics. (130 citations)
- Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion (103 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cardiology
- Myocardial infarction
Juan J. Badimon spends much of his time researching Internal medicine, Cardiology, Heart failure, Empagliflozin and Pharmacology.
His research brings together the fields of Endocrinology and Internal medicine.
His work on Ventricular remodeling, Thrombus and Antithrombotic as part of general Cardiology research is frequently linked to Macitentan, bridging the gap between disciplines.
His research integrates issues of Ketone bodies, Metabolism, Stent and Cholesterol, Lipoprotein in his study of Heart failure.
Juan J. Badimon has included themes like Ejection fraction and Canagliflozin in his Empagliflozin study.
His study in Pharmacology is interdisciplinary in nature, drawing from both Platelet activation, Platelet, Thrombin and Sodium Glucose Cotransporters.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
